Oncology Research Today is a free monthly online journal that collates and summarizes the latest research about Oncology, including details on cancer, surgery, chemotherapy, radiotherapy.

Volume 2 (2006), Issue 6 (June)

1. Symptoms in children/young people with progressive malignant disease: United Kingdom Children's Cancer Study Group/Paediatric Oncology Nurses Forum survey.
   Pediatrics, 117(6): e1179-86. [Abstract] [Full-text]
2. The cancer and leukemia group B oncology nursing committee (1983-2006): a history of passion, commitment, challenge, and accomplishment.
   Clin Cancer Res, 12(11): 3638s-41s. [Abstract] [Full-text]
3. Radiation oncology research in the cancer and leukemia group B.
   Clin Cancer Res, 12(11): 3628s-34s. [Abstract] [Full-text]
4. Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 Italian radiation oncology centers.
   Int J Radiat Oncol Biol Phys, 65(3): 788-99. [Abstract] [Full-text]
5. Pretreatment factors significantly influence quality of life in cancer patients: a Radiation Therapy Oncology Group (RTOG) analysis.
   Int J Radiat Oncol Biol Phys, 65(3): 830-5. [Abstract] [Full-text]
6. Symptom management needs of oncology outpatients.
   J Palliat Med, 9(3): 628-30. [Abstract] [Full-text]
7. ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology.
   Clin Nutr, 25(2): 245-59. [Abstract] [Full-text]
8. Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research.
   Blood, 107(12): 4961-7. [Abstract] [Full-text]
9. A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481.
   Blood, 107(12): 4606-13. [Abstract] [Full-text]
10. Southwest Oncology Group phase II study of arsenic trioxide in patients with refractory germ cell malignancies.
    Cancer, 106(12): 2624-9. [Abstract] [Full-text]
11. Therapeutic aspects of chaperones/heat-shock proteins in neuro-oncology.
    Expert Rev Anticancer Ther, 6(5): 679-95. [Abstract] [Full-text]
12. Phase II study of mitomycin-C, adriamycin, cisplatin (MAP) and Bleomycin-CCNU in patients with advanced cancer of the anal canal: An eastern cooperative oncology group study E7282.
    Invest New Drugs, 24(5): 447-54. [Abstract] [Full-text]
13. Asparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse: a Children's Oncology Group study (CCG-1941).
    Pediatr Blood Cancer, 47(2): 141-6. [Abstract] [Full-text]
14. Exercise and side effects among 749 patients during and after treatment for cancer: a University of Rochester Cancer Center Community Clinical Oncology Program Study.
    Support Care Cancer, 14(7): 732-41. [Abstract] [Full-text]
15. Diagnosis and treatment of catheter-related infections in paediatric oncology: an update.
    Clin Microbiol Infect, 12(7): 606-20. [Abstract] [Full-text]
16. Metronomic dosing of chemotherapy: applications in pediatric oncology.
    Cancer Invest, 24(4): 432-43. [Abstract] [Full-text]
17. Phase II clinical trials in oncology: strengths and limitations of two-stage designs.
    Cancer Invest, 24(4): 404-12. [Abstract] [Full-text]
18. Utility of a web-based breast cancer predictive algorithm for adjuvant chemotherapeutic decision making in a multidisciplinary oncology center.
    Cancer Invest, 24(4): 367-73. [Abstract] [Full-text]
19. Quality of life and pain in advanced stage prostate cancer: results of a Southwest Oncology Group randomized trial comparing docetaxel and estramustine to mitoxantrone and prednisone.
    J Clin Oncol, 24(18): 2828-35. [Abstract] [Full-text]
20. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.
    J Clin Oncol, 24(18): 2707-14. [Abstract] [Full-text]
21. American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.
    J Clin Oncol, 24(18): 2932-47. [Abstract] [Full-text]
22. The role of prevention in oncology practice: results from a 2004 survey of American Society of Clinical Oncology members.
    J Clin Oncol, 24(18): 2948-57. [Abstract] [Full-text]
23. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients.
    J Clin Oncol, 24(18): 2917-31. [Abstract] [Full-text]
24. Development of radiobiology for oncology-a personal view.
    Phys Med Biol, 51(13): R263-86. [Abstract] [Full-text]
25. Transdisciplinary studies of surgical oncology trial accrual: A National Institutes of Health/National Cancer Institute Roadmap-affiliated project update.
    Cancer, 107(1): 171-4. [Abstract] [Full-text]
26. Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group.
    Blood, 108(1): 74-80. [Abstract] [Full-text]
27. Incidental pulmonary emboli in oncology patients: prevalence, CT evaluation, and natural history.
    Radiology, 240(1): 246-55. [Abstract] [Full-text]
28. A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1).
    Ann Oncol, 17(7): 1111-9. [Abstract] [Full-text]
29. Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO).
    Ann Oncol, 17(7): 1051-9. [Abstract] [Full-text]
30. Health-related quality of life measurement in randomized clinical trials in surgical oncology.
    J Clin Oncol, 24(19): 3178-86. [Abstract] [Full-text]
31. Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study.
    J Clin Oncol, 24(19): 3142-9. [Abstract] [Full-text]
32. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941.
    J Clin Oncol, 24(19): 3150-6. [Abstract] [Full-text]

© 2005-2008 Oncology Research Today. All Rights Reserved.